Taro Pharmaceutical Industries Ltd. (TARO) Thursday reported an increase in profit for the fourth quarter, driven mainly by a 13.8 percent growth in revenues.
The Haifa Bay, Israel-based company's attributable net income for the fourth quarter was $49.2 million or $1.10 per share, compared to $47.3 million or $1.06 per share in the comparable quarter last year.
Total revenues for the quarter rose 13.8% to $165.13 million from $145.14 million in the prior-year quarter.
For comments and feedback: editorial@rttnews.com